FAST TRACK GROUP Completes Brand Activation Project for Electric Vehicle Brand Dongfeng Singapore

FAST TRACK GROUP Completes Brand Activation Project for Electric Vehicle Brand Dongfeng Singapore GlobeNewswire November 18, 2025 SINGAPORE, Nov. 18, 2025 (GLOBE NEWSWIRE) — FAST TRACK GROUP (NASDAQ: FTRK) (“Fast Track” or the “Company”), a leading entertainment-focused event management and celebrity agency company, announced the completion of a brand activation project for electric vehicle (EV) […]

NetraMark Signs Four New Contracts With a Leading Global Pharmaceutical Company To Enhance Clinical Trial Insights

NetraMark Signs Four New Contracts With a Leading Global Pharmaceutical Company To Enhance Clinical Trial Insights GlobeNewswire November 18, 2025 TORONTO, Nov. 18, 2025 (GLOBE NEWSWIRE) — NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the

Mirror Partners Launches Small Secondaries Strategy with Strategic Backing from East Rock Capital

Mirror Partners Launches Small Secondaries Strategy with Strategic Backing from East Rock Capital GlobeNewswire November 18, 2025 NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) — Mirror Partners LLC (“Mirror”), a secondaries private equity firm focused on small-cap secondary transactions, today announced its launch with strategic backing from East Rock Capital, LLC (“East Rock Capital”). Mirror

Precision Marshall Steel Achieves 99.98% Same-Day Shipment with New Customer Portal, Demonstrating Live Ventures’ Modernization Playbook

Precision Marshall Steel Achieves 99.98% Same-Day Shipment with New Customer Portal, Demonstrating Live Ventures' Modernization Playbook Digital investments and disciplined inventory management strengthen supply-chain reliability for U.S. manufacturers GlobeNewswire November 18, 2025 LAS VEGAS, Nov. 18, 2025 (GLOBE NEWSWIRE) — Live Ventures Incorporated (Nasdaq: LIVE), a diversified holding company, today announced that its portfolio company

Standard Lithium to Participate in Multiple Upcoming Investor Conferences

Standard Lithium to Participate in Multiple Upcoming Investor Conferences GlobeNewswire November 18, 2025 VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE.A: SLI), a leading near-commercial lithium company, will have senior leadership participating in multiple upcoming investor conferences. The Company will be participating in

Mawer Investment Management Ltd. Named One of Canada’s Top 100 Employers for 2026

Mawer Investment Management Ltd. Named One of Canada's Top 100 Employers for 2026 GlobeNewswire November 18, 2025 CALGARY, Alberta, Nov. 18, 2025 (GLOBE NEWSWIRE) — Mawer Investment Management Ltd. (“Mawer”) is honoured to be recognized once again as one of Canada's Top 100 Employers for 2026. This national award reflects Mawer's ongoing commitment to fostering

Observe.AI named a Cool Vendor in 2025 Gartner(R) Cool Vendors in Customer Service and Support Technology report

Observe.AI named a Cool Vendor in 2025 Gartner(R) Cool Vendors in Customer Service and Support Technology report Observe.AI has been named a Cool Vendor in the 2025 “Gartner (R) Cool Vendors(TM) in Customer Support and Technology” report GlobeNewswire November 18, 2025 SAN FRANCISCO, Nov. 18, 2025 (GLOBE NEWSWIRE) — Observe.AI, the leader in AI agents

Sustainable Fuel Market to Reach USD 299.9 Billion by 2029 | MarketsandMarkets(TM)

Sustainable Fuel Market to Reach USD 299.9 Billion by 2029 | MarketsandMarkets(TM) GlobeNewswire November 18, 2025 Delray Beach, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) — The global Sustainable Fuel Market size is expected to grow from USD 193.8 billion in 2024 to USD 299.9 billion by 2029, at a CAGR of 9.1% according to a

Radiopharm Theranostics Receives Approval to Initiate Phase 1 Therapeutic Trial of RAD 402 (KLK3-mAb with Tb161) in Advanced Prostate Cancer

Radiopharm Theranostics Receives Approval to Initiate Phase 1 Therapeutic Trial of RAD 402 (KLK3-mAb with Tb161) in Advanced Prostate Cancer GlobeNewswire November 18, 2025 RAD 402 is a humanized IgG1 internalized by prostate cells, binding KLK3 with high affinity Tb-161 antitumor activity driven by the dual emission of beta particles and Auger electrons SYDNEY, Nov.

Scroll to Top